Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

This study has been terminated.
Astellas Pharma US, Inc.
Information provided by:
Astellas Pharma Inc Identifier:
First received: February 24, 2005
Last updated: June 6, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given